Long-term persistence of memory B cells specific for hepatitis B surface antigen in HIV-1-infected patients

AIDS

Volumn 21, Issue 17, 2007, Pages 2343-2345

  Tuaillon, Edouard ^a,b   Tabaa, Yassine Al ^a,b   Baillat, Vincent ^a,c   Petitjean, Gaël ^a,b   Reynes, Jacques ^c   Vendrell, Jean Pierre ^a,b  

^a LAPEYRONIE HOSPITAL   (France)

^b INSERM   (France)

^c GUI DE CHAULIAC HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ANTIBODY PRODUCTION; ANTIVIRAL THERAPY; ARTICLE; BLOOD SAMPLING; COMPARATIVE STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSPOT ASSAY; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNITY; IMMUNIZATION; LINEAR REGRESSION ANALYSIS; LYMPHOCYTE SUBPOPULATION; MEMORY CELL; PRIORITY JOURNAL; SEROLOGY; VACCINATION; VIRUS REPLICATION;

ANTI-HIV AGENTS; ANTIBODIES, VIRAL; B-LYMPHOCYTES; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOLOGIC MEMORY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 37349111001     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32827035b5     Document Type: Article

References (17)

1. Piroth L, Binquet C, Vergne M, Minello A, Livry C, Bour JB, et al. The evolution of hepatitis B virus serological patterns and the clinical relevance of isolated antibodies to hepatitis B core antigen in HIV infected patients. J Hepatol 2002; 36:681-686.
2. Mast EE, Weinbaum CM, Fiore AE, Alter MJ, Bell BP, Finelli L, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP). Part II: immunization of adults. MMWR Recomm Rep 2006; 55:1-33.
3. Biggar R, Goedert J, Hoofnagle J. Accelerated loss of antibody to hepatitis B surface antigen among immunodeficient homosexual men infected with HIV. N Engl J Med 1987; 316:630-631.
4. Laukamm-Josten U, Muller O, Bienzle U, Feldmeier H, Uy A, Guggenmoos-Holzmann I. Decline of naturally acquired antibodies to hepatitis B surface antigen in HIV-1 infected homosexual men. AIDS 1988; 2:400-401.
5. Rodriguez-Mendez ML, Gonzalez-Quintela A, Aguilera A, Barrio E. Prevalence, patterns, and course of past hepatitis B virus infection in intravenous drug users with HIV-1 infection. Am J Gastroenterol 2000; 95:1316-1322.
6. Lascar RM, Lopes AR, Gilson RJ, Dunn C, Johnstone R, Copas A, et al. Effect of HIV infection and antiretroviral therapy on hepatitis B virus (HBV)-specific T cell responses in patients who have resolved HBV infection. J Infect Dis 2005; 191:1169-1179.
7. Bauer T, Jilg W. Hepatitis B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination. Vaccine 2006; 24:572-577.
8. Tuaillon E, Tabaa YA, Petitjean G, Huguet MF, Pajeaux G, Fondere JM, et al. Detection of memory B lymphocytes specific to hepatitis B virus (HBV) surface antigen (HBsAg) from HBsAg-vaccinated or HBV-immunized subjects by ELISPOT assay. J Immunol Methods 2006; 315:144-152.
9. Fondere JM, Huguet MF, Yssel H, Baillat V, Reynes J, Van de Perre P, Vendrell JP. Detection of peripheral HIV-1-specific memory B cells in patients untreated or receiving highly active antiretroviral therapy. AIDS 2003; 17:2323-2330.
10. Titanji K, De Milito A, Cagigi A, Thorstensson R, Grutzmeier S, Atlas A, et al. Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection. Blood 2006; 108:1580-1587.
11. Malaspina A, Moir S, Orsega SM, Vasquez J, Miller NJ, Donoghue ET, et al. Compromised B cell responses to influenza vaccination in HIV-infected individuals. J Infect Dis 2005; 191:1442-1450.
12. Bocher WO, Herzog-Hauff S, Herr W, Heermann K, Gerken G, Meyer Zum Buschenfelde KH, Lohr HF. Regulation of the neutralizing antihepatitis B surface (HBs) antibody response in vitro in HBs vaccine recipients and patients with acute or chronic hepatitis B virus (HBV) infection. Clin Exp Immunol 1996; 105:52-58.
13. Michalak TI, Pasquinelli C, Guilhot S, Chisari FV. Hepatitis B virus persistence after recovery from acute viral hepatitis. J Clin Invest 1994; 93:230-239.
14. Rehermann B, Ferrari C, Pasquinelli C, Chisari FV. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med 1996; 2:1104-1108.
15. Tenner-Racz K, Stellbrink HJ, Van Lunzen J, Schneider C, Jacobs JP, Raschdorff B, et al. The unenlarged lymph nodes of HIV-1-infected, asymptomatic patients with high CD4 T cell counts are sites for virus replication and CD4 T cell proliferation. The impact of highly active antiretroviral therapy. J Exp Med 1998; 187:949-959.
16. Blankson JN, Bailey JR, Thayil S, Yang HC, Lassen K, Lai J, et al. Isolation and characterization of replication-competent human immunodeficiency virus type 1 from a subset of elite suppressors. J Virol 2007; 81:2508-2518.
17. Fournier AM, Baillat V, Alix-Panabieres C, Fondere JM, Merle C, Segondy M, et al. Dynamics of spontaneous HIV-1 specific and nonspecific B-cell responses in patients receiving antiretroviral therapy. AIDS 2002; 16:1755-1760.